Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
Plos One
De Grève, Jacques J; Van Meerbeeck, Jan J; Vansteenkiste, Johan F JF; Decoster, Lore L; Meert, Anne-Pascale AP; Vuylsteke, Peter P; Focan, Christian C; Canon, Jean-Luc JL; Humblet, Yves Y; Berchem, Guy G; Colinet, Benoit B; Galdermans, Danny D; Bosquée, Lionel L; Vermeij, Joanna J; Dewaele, Alex A; Geers, Caroline C; Schallier, Denis D; Teugels, Erik E
Publication Date: 2016
Variant appearance in text: EGFR: 2311_2312insCCA; Asp770_Asn771insThr